How is mesothelioma staged?
Mesothelioma stages are the  assessment levels that 
doctors utilize to determine the extent of the  cancer within the body. Mesothelioma is staged between 1 and 4, depending on  severity. Stage 1 mesothelioma, for instance, is highly localized disease, with  the 
tumor affecting  only a limited area and organ tissue. Stage 4 cancer, on the other extreme, is  extensive disease, which has spread far beyond the tumor’s origin, affecting  other organ tissue and even blood or bone cells.
Given how rare mesothelioma  is, a formal staging classification exists only for pleural mesothelioma, which  affects the lining of the lung and chest cavity. Staging is determined at 
diagnosis, using any number of diagnostic procedures. Basic staging can be  determined through the use of 
imaging scans,  which will provide cancer specialists a visual representation of the extent of  the tumor within the body. If the results of imaging scans are inconclusive or  it appears that the disease is not localized, a physician may request the  patient to undergo a needle or surgical biopsy, which can determine if  the 
malignant cells have 
metastasized to the blood or lymph nodes through laboratory testing.
Mesothelioma Staging Systems
Today, there are three  primary staging systems used to assess how far mesothelioma cancer has spread  and each system uses four stages to describe the progression of the disease. It  is the definition of each stage within the various systems that can vary  slightly.
The Butchart staging system  is the oldest and most commonly utilized staging system for mesothelioma. This  system is focused on defining the location of the primary tumor mass in the  body for each stage. The system doesn’t address how many cancer cells are present,  how big the tumor is or the level of cancer present in the body overall.
The TNM Staging System,  developed by the American Joint Committee on Cancer (AJCC), is similar to  staging systems used for other types of cancer. It considers the  characteristics of the tumor (T), whether or not lymph nodes are involved (N)  and if the cancer has metastasized to other locations in the body (M).
The Brigham Staging System  also has four stages of progression and is very similar to the TNM Staging  System. The primary difference between the two is that in addition to defining  the location of the tumor, and assessing lymph node involvement and the  presence of metastatic disease, the 
Brigham System also helps assess the possibility for and effectiveness of  surgical intervention at each stage.
The Stages of Mesothelioma
The four stages of  mesothelioma, as noted above, vary slightly within each system but can be  generally characterized as indicated below. Please click into the individual  pages to get more information about each stage in general and as is it defined  within each staging system:
In Stage 1 the tumor is  localized, there is no lymph node involvement, and the cancer has not spread to  other organs or tissues. In this case, the cancer is likely restricted to one  side of the pleura and surgical removal is typically feasible. 
In Stage 2, the tumor is  larger and has invaded the lung or diaphragm. Lymph nodes may also be involved.  In this case, surgical resection may be possible though the cancer has likely  spread to both sides of the pleura.
In Stage 3, mesothelioma has invaded a single  region or area such as the chest wall, esophagus, and/or lymph nodes, and  surgical resection is generally ruled out as a potential beneficial treatment.
In Stage 4, mesothelioma  has invaded multiple regions such as different areas of the chest wall, the  diaphragm and/or the pericardium. Lymph nodes are also  involved and the cancer has spread to other organs. Surgical removal provides  no value in this case as the disease has likely metastasized well beyond its  origin.
No comments:
Post a Comment